Akari Therapeutics Total Assets (Quarterly) Insights

Akari Therapeutics PLC (AKTX)

1.47 -0.23 (-13.53%) USD | NASDAQ | May 02, 16:00

1.47 0.00 (0.00%) After-Hours: 19:59

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	4.355M
June 30, 2023	8.013M
June 30, 2022	11.37M
March 31, 2022	19.45M
December 31, 2021	11.65M
September 30, 2021	14.72M
June 30, 2021	4.830M
March 31, 2021	7.840M
December 31, 2020	14.60M
September 30, 2020	13.69M
June 30, 2020	14.45M
March 31, 2020	9.969M
December 31, 2019	6.480M
September 30, 2019	10.67M
June 30, 2019	5.151M
March 31, 2019	8.810M
December 31, 2018	8.030M

Date	Value
September 30, 2018	12.63M
June 30, 2018	17.12M
March 31, 2018	25.50M
December 31, 2017	29.05M
September 30, 2017	22.43M
June 30, 2017	32.05M
March 31, 2017	36.52M
December 31, 2016	45.87M
September 30, 2016	52.07M
June 30, 2016	57.63M
March 31, 2016	62.96M
December 31, 2015	69.89M
September 30, 2015	79.17M
June 30, 2015	2.96M
March 31, 2015	4.317M
December 31, 2014	3.395M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

4.355M

Minimum

Dec 2023

19.45M

Maximum

Mar 2022

10.48M

Average

10.67M

Median

Sep 2019

Total Assets (Quarterly) Benchmarks

DBV Technologies SA	182.99M
Adaptimmune Therapeutics PLC	282.62M
Biodexa Pharmaceuticals Plc	13.43M
NuCana PLC	35.43M
Genfit SA	192.20M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly)	4.584M
Shareholders Equity (Quarterly)	-0.229M